Human Papillomavirus Vaccine and Postural Orthostatic Tachycardia Syndrome: A Review of Current Literature

Journal of Child Neurology

Volumn 32, Issue 11, 2017, Pages 956-965

  Butts, Breann N ^a   Fischer, Philip R ^b   MacK, Kenneth J ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

adolescent; autoimmune; children; epidemiology; human papillomavirus (HPV); human papillomavirus (HPV) vaccine; pediatric; postural orthostatic tachycardia syndrome (POTS); quality of life; risk factors; vaccination

Indexed keywords

WART VIRUS VACCINE;

CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; DIZZINESS; DYSAUTONOMIA; HEART RATE; HUMAN; PAPILLOMAVIRUS INFECTION; PHYSICAL EXAMINATION; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK FACTOR; IMMUNOLOGY;

HUMANS; PAPILLOMAVIRUS VACCINES; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME;

EID: 85029043776     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073817718731     Document Type: Review

References (53)

1. Human papillomavirus (HPV) and cervical cancer: fact sheet N°380. World Health Organization 2016.; http://www.who.int/mediacentre/factsheets/fs380/en/. Accessed March 15, 2016.
2. HPV vaccine information for clinicians. Centers for Disease Control and Prevention 2016.; http://www.cdc.gov/hpv/hcp/need-to-know.pdf. Accessed March 15, 2016.
3. Markowitz LE, Dunne E, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63 (RR-05): 1-30.
4. Human papillomavirus (HPV) vaccine background paper. World Health Organization 2008.; http://www.who.int/immunization/documents/HPVBGpaper-final-03-04-2009.pdf. Accessed March 15, 2016.
5. Cervarix: highlights of prescribing information. [Package insert]. GlaxoSmithKline 2009.; http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM186981.pdf. Accessed March 15, 2016.
6. Gardasil: highlights of prescribing information. [Package insert]. Merck & Co., Inc. http://www.merck.com/product/usa/pi-circulars/g/gardasil/gardasil-pi.pdf. Published 2006. Accessed March 15, 2016.
7. Gardasil 9: highlights of prescribing information. [Package insert]. Merck & Co., Inc. https://www.merck.com/product/usa/pi-circulars/g/gardasil-9/gardasil-9-pi.pdf. Published 2014. Accessed March 15, 2016.
8. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356: 1915-1927.
9. Vaccine Adverse Event Reporting System (VAERS). US Department of Health and Human Services 2017.; https://vaers.hhs.gov/index. Accessed March 16, 2016.
10. Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA,. Postural tachycardia in children and adolescents: what is abnormal? J Pediatr. 2012; 160: 222-226.
11. Kizilbash SJ, Ahrens SP, Bruce BK, et al. Adolescent fatigue, POTS, and recovery: a guide for clinicians. Curr Probl Pediatr Adolesc Health Care. 2014; 44: 108-133.
12. Ojha A, Chelimsky TC, Chelimsky G,. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr. 2011; 158: 20-23.
13. Bhatia R, Kizilbash SJ, Ahrens SP, et al. Outcomes of adolescent-onset postural orthostatic tachycardia syndrome. J Pediatr. 2016; 173: 149-153.
14. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007; 82: 308-313.
15. Wang XL, Chai Q, Charlesworth MC, et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl. 2012; 6: 615-625.
16. Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014; 3: e000755.
17. Blitshteyn S,. Postural tachycardia syndrome after vaccination with Gardasil. Eur J Neurol. 2010; 17: e52.
18. Blitshteyn S,. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol. 2014; 21: 135-139.
19. Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y,. Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the "autoimmune/auto-inflammatory syndrome induced by adjuvants": case report and literature review. J Investig Med High Impact Case Rep. 2014; 2: 2324709614527812.
20. Kinoshita T, Abe RT, Hineno A, Tsunekawa K, Nakane S, Ikeda S,. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med. 2014; 53: 2185-2200.
21. Brinth LS, Pors K, Theibel AC, Mehlsen J,. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015; 33: 2602-2605.
22. Hendrickson JE, Tormey CA,. Human papilloma virus vaccination and dysautonomia: considerations for autoantibody evaluation and HLA typing. Vaccine. 2016; 34: 4468.
23. Brinth L, Theibel AC, Pors K, Mehlsen J,. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J. 2015; 62: A5064.
24. Blitshteyn S, Brook J,. Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination. Immunol Res. 2017; 65: 282-284.
25. Martínez-Lavín M, Martínez-Lavín LA, Reyes-Loyola P,. HPV vaccination syndrome: a questionnaire-based study. Clin Rheumatol. 2015; 34: 1981-1983.
26. Dahan S, Tomljenovic L, Shoenfeld Y,. Postural orthostatic tachycardia syndrome (POTS)-a novel member of the autoimmune family. Lupus. 2016; 25: 339-342.
27. Chao C, Klein NP, Velicer CM, et al. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012; 271: 193-203.
28. Klein NP, Hansen J, Chao C, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012; 166: 1140-1148.
29. Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR, Noren GN,. Current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in VigiBase®. Drug Saf. 2017; 40: 81-90.
30. Baker B, Eca Guimaraes L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y,. The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases. Expert Opin Drug Saf. 2015; 14: 1387-1394.
31. Chustecka Z,. Japan scheme for managing symptoms after HPV vaccine. Medscape Medical News. http://www.medscape.com/viewarticle/850436. Published September 2015. Accessed March 15, 2016.
32. Chustecka Z,. Safety profile of HPV vaccines under review in Europe. Medscape Medical News. http://www.medscape.com/viewarticle/847841. Published July 2015. Accessed March 15, 2016.
33. Martínez-Lavín M,. Hypothesis: human papillomavirus vaccination syndrome: small fiber neuropathy and dysautonomia could be its underlying pathogenesis. Clin Rheumatol. 2015; 34: 1165-1169.
34. Hendrickson JE, Hendrickson ET, Gehrie EA, et al. Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. J Clin Apher. 2016; 31: 368-374.
35. McCulloch v. Secretary of Health and Human Services. United States Court of Federal Claims, 09-293V. https://ecf.cofc.uscourts.gov/cgi-bin/show-public-doc?2009vv0293-152-0. Published May 22, 2015. Accessed April 19, 2017.
36. L.A.M. v. Secretary of Health and Human Services. United States Court of Federal Claims, 11-852V. https://ecf.cofc.uscourts.gov/cgi-bin/show-public-doc?2011vv0852-131-0. Published January 31, 2017. Accessed April 19, 2017.
37. Winker R, Prager W, Haider A, Salameh B, Rudiger HW,. Schellong test in orthostatic dysregulation: a comparison with tilt-table testing. Wien Klin Wochenschr. 2005; 117: 36-41.
38. Hanley SJ, Pollock KG, Cuschieri K,. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med. 2015; 54: 1953.
39. Kinoshita T, Ikeda S,. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med. 2015; 54: 1955.
40. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W,. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012; 87: 1196-1201.
41. Petousis-Harris H,. Proposed HPV vaccination syndrome is unsubstantiated. Clin Rheumatol. 2016; 35: 833-834.
42. Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 0 through 18 years, United States. http://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html. Published 2017. Accessed March 16, 2016.
43. Grimaldi-Bensouda L, Guillemot D, Godeau B, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med. 2014; 275: 398-408.
44. Wilson RP, Paterson P, Larson HJ,. The HPV vaccination in Japan: issues and options. Centers for Disease Control and Prevention website. http://csis.org/files/publication/140514-Wilson-HPVVaccination-Web.pdf. Published 2014. Accessed March 22, 2016.
45. Japanese Ministry of Health, Labour and Welfare. The public hearing on adverse events following HPV vaccine in Japan. http://www.mhlw.go.jp/stf/shingi/0000048229.html. Published 2014. Accessed August 25, 2016.
46. Danish Health and Medicines Authority. Danish pharmacovigilance update: The HPV vaccine and reported suspected adverse reactions. https://laegemiddelstyrelsen.dk/en/news/2014/a1/4/media/0540230CC7344D6589018F88BB171F51.ashx. Published 2014. Accessed March 16, 2016.
47. European Medicines Agency. Review concludes evidence does not support that HPV vaccines cause CRPS or POTS. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2015/11/news-detail-002429.jsp&mid=WC0b01ac058004d5c1. Published May 2015. Accessed March 16, 2016.
48. Jefferson T, Jørgensen L,. Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction-a review of the regulatory evidence from the European Medicines Agency. Indian J Med Ethics. 2017; 2: 30-37.
49. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017; 92: 241-268. http://apps.who.int/iris/bitstream/10665/255353/1/WER9219.pdf?ua=1. Accessed May 23, 2017.
50. La Vigne P,. HPV vaccines raise international red flags. The Vaccine Reaction. http://www.thevaccinereaction.org/2015/10/hpv-vaccines-raise-international-red-flags/. Published October 2015. Accessed March 17, 2016.
51. Health Resources & Services Administration, US Department of Health and Human Services. About the National Vaccine Injury Compensation Program. http://www.hrsa.gov/vaccinecompensation/about/index.html. Published 2016. Accessed March 16, 2016.
52. SaneVax, Inc. SaneVax: safe, affordable, necessary & effective vaccines and vaccination practices. http://sanevax.org/. Accessed March 16, 2016.
53. Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press; 2011.